3-Substituted biquinolinium inhibitors of AraC family transcriptional activator VirF from S. flexneri obtained through in situ chemical ionization of 3,4-disubstituted dihydroquinolines
Continuous Flow Synthesis of Quinolines via a Scalable Tandem Photoisomerization‐Cyclization Process
作者:Mara Di Filippo、Marcus Baumann
DOI:10.1002/ejoc.202000957
日期:2020.10.22
A continuous flow process exploiting a light‐driven method for generating a series of drug‐like quinolines is reported and applied to the synthesis of the alkaloid natural product galipinine.
Quinoline-indole antimicrobial agents, uses and compositions related thereto
申请人:Sepracor Inc.
公开号:US06376670B1
公开(公告)日:2002-04-23
The present invention provides methods and pharmaceutical preparations that inhibit the growth of bacterial microorganisms, via a non-lytic mechanism. Additionally, the present invention provides methods and pharmaceutical preparations that kill bacterial microorganisms, via a non-lytic mechanism.
Quinoline-indole antimicrobial agents, uses and compositions related
申请人:Sepracor, Inc.
公开号:US06103905A1
公开(公告)日:2000-08-15
The present invention provides methods and pharmaceutical preparations that inhibit the growth of bacteria microorganisms. Additionally, the present invention provides methods and pharmaceutical preparations that kill bacterial microorganisms.
dehydrogenative coupling of benzocyclic amines with indolederivatives that enables to access various quinoline-indole linked N-biheteroarenes in an efficient manner. The catalytic transformation is characteristic of operational simplicity, a readily available catalyst system, good substrate and functional compatibility, mild conditions, high atom efficiency, and no need for oxidant and halogenated coupling agents
[EN] BINDING FUNCTION3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE<br/>[FR] COMPOSÉS DE SITE DE (BF3) AYANT UNE FONCTION 3 DE LIAISON UTILISÉS EN TANT QU'AGENTS THÉRAPEUTIQUES ET LEURS PROCÉDÉS D'UTILISATION
申请人:UNIV BRITISH COLUMBIA
公开号:WO2015154169A1
公开(公告)日:2015-10-15
This invention provides compound having a structure of Formulas: Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provide.